See Current Funding Opportunities - February 19, 2018
Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
Funding Opportunity Purpose
HIV+ alcohol users remain at high risk for medication non-adherence and rapid disease progression, medication toxicities, organ failure, and poor viremic control, leading to increased risk of transmission and premature death. Recent advances in technology and biomedical science (e.g., new pharmacological agents, alcohol and inflammation biomarkers, internet and mobile technology) open new opportunities for strengthening the quality of HIV/alcohol-related implementation research through utilization of novel technology and biomarkers.
This initiative seeks to advance knowledge on implementation and comparative effectiveness of alcohol-focused interventions among HIV+ individuals. Multiple factors need to be investigated, including potentially important patient and provider characteristics, and the organizational, financial, and structural factors that facilitate or inhibit the delivery of evidence-based services for HIV+ individuals with a range of severity of alcohol use problems.
The overall goal is to inform clinical decision-making to implement effective interventions that will improve prevention, care, and outcomes across the continuum of HIV and alcohol problem severity and patterns of alcohol use. This solicitation is divided into two major topics. An application may choose to address one or both. These topics include: 1) comparative effectiveness research focused on understanding factors related to early detection, patient engagement and retention in appropriate alcohol and HIV care, and achieving and maintaining optimal treatment responses in diverse settings, and 2) modeling and testing alternative implementation approaches to improve uptake and scaling-up of effective interventions and reduce HIV disease transmission and progression.
FOA PAR17-474, Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (LMICs)
Seeks to stimulate new and impactful research towards the development of stigma reduction interventions leading to better outcomes for the prevention and treatment of HIV/AIDS and on the quality of life of People Living with HIV/AIDS (PLWH) in LMICs. Please click below for more information.
PAR-17-471, Detection of HIV for Self-Testing (R61/R33)
Publication date: August 25, 2017
Due dates: December 6, 2017, December 6, 2018, and December 6, 2019 (one receipt date per year)
Purpose: NIAID and NIMH are encouraging grant applications for bi-phasic developmental, proof-of-concept research focused on innovative strategies to detect HIV within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. The goal is to develop simple diagnostic tools that would be feasible for a self-testing platform to allow untrained individuals to detect HIV.
Proposed research projects should establish proof-of-concept for simple qualitative or semi-quantitative diagnostic assays that directly detect HIV (RNA, DNA, and/or protein) or other biomarkers that reliably correlate with viral load or rebound. Such assays would complement existing self-testing tools that detect the host antibody response to HIV. Research objectives may include either the initial development of a novel technology or adaptation of an emerging technology to detect HIV in a self-test platform. Interdisciplinary collaborations that include biomedical, physical, and behavioral sciences are highly encouraged.
HIV/HCV Co-Infections in Substance Abusers (R01)
Funding Type: NIDA
Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.
URL to RFP: https://grants.nih.gov/grants/guide/pa-files/PAS-17-311.html
Release Date: June 13, 2017
Due Date: September 7 2017 and January 7, 2018 , by 5:00 PM local time of applicant organization.
Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to fill gaps in our understanding of (a) the impact of substance abuse on HIV, HIV/HCV co-infection associated disease progression, (b) the pathogenic interactions between HIV and hepatitis C virus, (c) hepatic and non-hepatic co-morbidities associated with HIV/HCV-co-infections in people with substance abuse disorders (SUDs), and (d) the effectiveness of interferon-free direct acting antiviral (DAAs) drug regimens to treat HIV/HCV co-infections in people with SUDs. This FOA is informed by priority area in the NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html and the HHS National Viral Hepatitis Action Plan 2017-2020: https://www.hhs.gov/hepatitis/blog/2017/01/19/updated-national-viral-hepatitis-action-plan-2017-2020.html
New NCI RFA : RFA-CA-17-030: HIV/AIDS and the Tumor Niche (R01)
NIH new FOA on phylodynamic tracking of HIV transmission (R01)
New funding opportunity announcement: PAR-17-048: Phylodynamic Tracking of HIV Transmission (R01). Current set-aside funds for this initiative are $4.39 million, and applications for the first round of funding will be due March 15, 2017.
Please contact Dr. Lillian Kuo (firstname.lastname@example.org) with any questions about applying to this PAR.
Apply now for the UCSF CAPS Visiting Professors Program
The UCSF Center for AIDS Prevention Studies (CAPS) has a Visiting Professors program to train investigators in conducting research with ethnic minority communities. The VP Program is designed to assist investigators already conducting HIV-prevention research with minority communities to improve their programs of research and obtain additional funding for their work. It includes a 6-week summer residency, pilot funding, and other mentorship and career development opportunities. More information is described below and at their website: http://vp.ucsf.edu/.
A new AIDS and cancer funding announcement was published in the NIH Guide.
Here are the links for "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers:
Open Date: December 7, 2016
Deadline: January 7, 2017
Expiration Date: September 8, 2019
Open Date: December 7, 2016
Deadline: January 7, 2017
Expiration Date: September 8, 2019
UCLA mSTUDY Databank - REQUEST FOR PROPOSALS
For clinical data, behavioral data, and biospecimens from the mSTUDY Biorepository
New Biosketch Format - Doc
Duke Website and Newsletter offer extensive list of funding opportunities.
Duke’s Office of Research Support website provides an extensive database of funding opportunities of interest to the Duke Community. The list is searchable by discipline, eligibility, sponsor, etc.
To view a list of funding opportunities: https://researchfunding.duke.edu/index.asp
The Office of Research Support highlights new funding opportunities each week through its newsletter, which is published on Monday morning. The newsletter publishes new and recently updated announcements of federal and private funding for research, fellowships, curriculum, and program development.
Subscribe to receive the newsletter: https://researchfunding.duke.edu/subscribe.asp
The CFAR issues 2 RFP's per year (Spring and Fall). Additional RFP's may be issued in collaboration with our Strategic Partners or to support Emerging Opportunities.
The intent of a CFAR Developmental Core is to support scientific studies for a period of 1 year to develop preliminary data for peer-reviewed research applications. Four general areas are eligible for support through the Developmental Core:
- Investigators who are new to HIV/AIDS research and have not previously received independent research awards such as an R01 in HIV/AIDS research
- Feasibility Studies
- Emerging research opportunities
- HIV/AIDS research activities of newly recruited faculty
Additional information regarding eligibility:
- High priority for developmental awards will be given to junior faculty.
- The CFAR Development Core may be used to fund a collaborative study that encompasses two different scientific disciplines that may not have collaborated previously.
- Graduate students lacking a terminal degree are not eligible.
- Fellows (postdoctoral fellows, clinical fellows) become eligible to apply for funding after completing at least 6 months of their fellowship.
- Prior approval from NIH Program Staff is required for developmental awards to senior investigators.
- The use of the CFAR Cores for development and implementation of your proposal is strongly encouraged.
- The CFAR Executive Committee is willing to consider funding meritorious CFAR Small Grant applications from investigators who have previously received CFAR Small Grant awards if:
- the previous CFAR Small Grant award was productive (i.e., resulted in peer-reviewed publications and/or subsequent funding)
- the “new” CFAR Small Grant application is in a research area different than the originally funded proposal (i.e. not an extension of the original work), and
- the new application receives a fundable score.
- Previous CFAR Small Grant recipients must have pre-approval from CFAR Developmental Core Director (email@example.com) before submitting a proposal.